These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 381989)

  • 1. [Functional nephropathy in the course of hepatic cirrhosis. Pathogenetic relationships with changes in hepatic blood flow].
    Merkel C; Zuin R; Grassetto M; Milani L; Merlo A; Gatta A
    Minerva Nefrol; 1979; 26(1):33-6. PubMed ID: 381989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and functional aspects of the kidney in relation to renal and intrarenal hemodynamic changes during hepatic cirrhosis].
    Gatta A; Merkel C; Milani L; Caregaro L; Grassetto M; Lauro S; Zuin R
    Minerva Nefrol; 1979; 26(1):37-40. PubMed ID: 381990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Renal blood flow in hepatic cirrhosis determined by the Xe 133 washout method].
    Zuin R; Gatta A; Prandoni P; Finocchio GF; Merkel C; Ruol A
    Minerva Nefrol; 1976; 23(2):109-15. PubMed ID: 794762
    [No Abstract]   [Full Text] [Related]  

  • 4. [Decrease in medio-renal and cortical renal blood flow in liver cirrhosis. Relationships with changes in systemic hemodynamics].
    Zuin R; Merkel C; Grassetto M; Milani L; Merlo A; Gatta A
    Minerva Nefrol; 1979; 26(1):41-4. PubMed ID: 381991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal hemodynamic disorders in hepatic cirrhosis].
    Oancea R
    Med Interna (Bucur); 1970 Feb; 22(2):131-5. PubMed ID: 5444352
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 7. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
    Bizer LS
    Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preoperative evaluation of hemodynamics and the functional state of the liver in cirrhosis].
    Anisimova SM
    Vestn Khir Im I I Grek; 1972 Dec; 109(12):32-5. PubMed ID: 4664077
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physiopathology of nephropathy in liver cirrhosis. Pathogenetic role of ascites and of inferior vena cava pressure increase].
    Gatta A; Zuin R; Merkel C; Milani L; Ruol A
    Minerva Dietol Gastroenterol; 1979; 25(1):9-16. PubMed ID: 450267
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional and non-functional liver blood flow in patients with liver cirrhosis measured by indocyanine green.
    Perlik F; Janku I; Jedlicka J
    Methods Find Exp Clin Pharmacol; 1992; 14(6):459-64. PubMed ID: 1469955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic interrelations in portal hypertension caused by hepatic cirrhosis].
    Garcia Civera R; Benages Martínez A; Lopez Merino F; Garcia-Conde Gomez FJ
    Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):19-34. PubMed ID: 5069488
    [No Abstract]   [Full Text] [Related]  

  • 12. [Echographic and hemodynamic indicators in liver cirrhosis with portal hypertension].
    Rikhsieva LE; Akhmedzhanova ShSh; Miasnik BN
    Sov Med; 1989; (2):13-5. PubMed ID: 2658117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of hepatic blood flow by the rectal Xe-133 clearance method].
    Kalantarov KD; Platova IR; Evdokimov EA; Osipov SA; Marintsev VN
    Med Radiol (Mosk); 1982 Feb; 27(2):37-41. PubMed ID: 7040901
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
    Lebrec D; Sicot C; Benhamou JP
    Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renal and intrarenal hemodynamics in the course of hepatic cirrhosis before and after porto-systemic shunt].
    Gatta A; Merkel C; Zuin R; Milani L; Baccaglini U; Grassetto M; Spina GP
    Minerva Nefrol; 1979; 26(2):119-23. PubMed ID: 471336
    [No Abstract]   [Full Text] [Related]  

  • 16. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
    Orrego Matte H
    Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiopathology of portal hypertension in liver cirrhosis].
    Cervela LA
    Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver cirrhosis and the renin-angiotensin-aldosterone system].
    Lozano de León F; Leal M; Lissen E
    Rev Esp Enferm Apar Dig; 1986 Nov; 70(5):465-8. PubMed ID: 3797771
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein content of liver lymph in patients with portal hypertension secondary to hepatic cirrhosis.
    Dumont AE; Witte CL; Witte MH
    Lymphology; 1975 Dec; 8(4):111-3. PubMed ID: 1214504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
    Vorob'ev LP; Maev IV; Andreev NG
    Klin Med (Mosk); 1991 Feb; 69(2):64-7. PubMed ID: 1875666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.